IR-Med Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year Ending	TTM	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Net Income	-4.22	-4.91	-9.46	-3.72	-0.76	-0.25
Depreciation & Amortization	0.02	0.02	0.01	0.01	0	0
Share-Based Compensation	0.99	1.68	1.33	1.34	0.03	0
Other Operating Activities	0.52	-0.02	4.75	-0.11	0.33	0.17
Operating Cash Flow	-2.69	-3.23	-3.38	-2.48	-0.4	-0.07
Capital Expenditures	-0	-0	-0.05	-0.03	0	0
Change in Investments	-	-	-0.01	-0.03	-	-
Other Investing Activities	-	-	-	-	-	-0.23
Investing Cash Flow	-0	-0	-0.06	-0.06	0	-0.23
Common Stock Issued	1	1	3.63	3.49	2.04	0.3
Other Financing Activities	0.75	-	-	-	-	-
Financing Cash Flow	1.75	1	3.63	3.49	2.04	0.3
Net Cash Flow	-1.7	-2.24	0.19	0.95	1.63	0
Free Cash Flow	-2.69	-3.23	-3.43	-2.51	-0.4	-0.07
Free Cash Flow Margin	-7917.65%	-	-	-	-	-
Free Cash Flow Per Share	-0.04	-0.05	-0.05	-0.04	-0.01	-0.00

Sources: The data provider is Financial Modeling Prep and the numbers are sourced from SEC filings.